Holdings
Deerfield Management Company, L.P.
As of Sep 30, 2026, Deerfield Management Company, L.P. reported 63 positions worth US$4.94B. Largest: Revolution Medicines, Inc., Centene Corporation and United Therapeutics Corporation. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 2.12M | US$436M | −268K | Sep 30, 2026 |
| Centene Corporation | 4.9M | US$304M | no change | Sep 30, 2026 |
| United Therapeutics Corporation | 541K | US$293M | +83,598 | Sep 30, 2026 |
| Praxis Precision Medicines, Inc. | 963K | US$281M | no change | Sep 30, 2026 |
| Genmab A/S | 6.87M | US$245M | no change | Sep 30, 2026 |
| Viatris Inc. | 10.9M | US$194M | −9.27M | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 5.96M | US$191M | +951K | Sep 30, 2026 |
| Celcuity Inc. | 2.4M | US$191M | +947K | Sep 30, 2026 |
| Legend Biotech Corp. | 8.14M | US$162M | new | Sep 30, 2026 |
| Vera Therapeutics, Inc. | 4.34M | US$140M | +422K | Sep 30, 2026 |